Annual Accounts Receivable
$352.80 K
+$92.40 K+35.48%
June 30, 2024
Summary
- As of February 7, 2025, INM annual accounts receivable is $352.80 thousand, with the most recent change of +$92.40 thousand (+35.48%) on June 30, 2024.
- During the last 3 years, INM annual accounts receivable has risen by +$340.90 thousand (+2864.71%).
- INM annual accounts receivable is now -42.55% below its all-time high of $614.10 thousand, reached on June 30, 2005.
Performance
INM Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$284.70 K
-$68.10 K-19.30%
September 30, 2024
Summary
- As of February 7, 2025, INM quarterly accounts receivable is $284.70 thousand, with the most recent change of -$68.10 thousand (-19.30%) on September 30, 2024.
- Over the past year, INM quarterly accounts receivable has increased by +$77.00 thousand (+37.07%).
- INM quarterly accounts receivable is now -75.10% below its all-time high of $1.14 million, reached on December 31, 2004.
Performance
INM Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
INM Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.5% | +37.1% |
| 3 y3 years | +2864.7% | +223.5% |
| 5 y5 years | +445.3% | +83.9% |
INM Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2864.7% | -23.6% | +1773.0% |
| 5 y | 5-year | at high | +2864.7% | -23.6% | +2292.4% |
| alltime | all time | -42.5% | +2864.7% | -75.1% | -100.0% |
InMed Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $284.70 K(-19.3%) |
| Jun 2024 | $352.80 K(+35.5%) | $352.80 K(+69.9%) |
| Mar 2024 | - | $207.70 K(-44.3%) |
| Dec 2023 | - | $372.90 K(+124.9%) |
| Sep 2023 | - | $165.80 K(-36.3%) |
| Jun 2023 | $260.40 K(+195.9%) | $260.40 K(+52.9%) |
| Mar 2023 | - | $170.30 K(+108.7%) |
| Dec 2022 | - | $81.60 K(+436.8%) |
| Sep 2022 | - | $15.20 K(-82.7%) |
| Jun 2022 | $88.00 K(+639.5%) | $88.00 K(+24.6%) |
| Mar 2022 | - | $70.60 K(+40.4%) |
| Dec 2021 | - | $50.30 K(+239.9%) |
| Sep 2021 | - | $14.80 K(+24.4%) |
| Jun 2021 | $11.90 K(-73.7%) | $11.90 K(-83.1%) |
| Mar 2021 | - | $70.30 K(-54.6%) |
| Dec 2020 | - | $154.80 K(+198.3%) |
| Sep 2020 | - | $51.90 K(+14.6%) |
| Jun 2020 | $45.30 K(-30.0%) | $45.30 K(+41.1%) |
| Mar 2020 | - | $32.10 K(-50.7%) |
| Dec 2019 | - | $65.10 K(+114.9%) |
| Sep 2019 | - | $30.30 K(-53.2%) |
| Jun 2019 | $64.70 K(+59.4%) | $64.70 K(+12.3%) |
| Mar 2019 | - | $57.60 K(+69.4%) |
| Dec 2018 | - | $34.00 K(-16.3%) |
| Jun 2018 | $40.60 K(-77.9%) | $40.60 K(>+9900.0%) |
| Mar 2009 | - | $0.00(-100.0%) |
| Dec 2008 | - | $27.60 K(-77.1%) |
| Sep 2008 | - | $120.60 K(-34.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2008 | $183.90 K(-11.7%) | $183.90 K(-35.0%) |
| Mar 2008 | - | $282.80 K(+64.1%) |
| Dec 2007 | - | $172.30 K(+13.3%) |
| Sep 2007 | - | $152.10 K(-27.0%) |
| Jun 2007 | $208.30 K(-49.2%) | $208.30 K(-26.9%) |
| Mar 2007 | - | $285.10 K(+2.7%) |
| Dec 2006 | - | $277.50 K(-14.3%) |
| Sep 2006 | - | $323.80 K(-21.1%) |
| Jun 2006 | $410.40 K(-33.2%) | $410.40 K(-13.5%) |
| Mar 2006 | - | $474.30 K(-14.5%) |
| Dec 2005 | - | $554.60 K(+5.5%) |
| Sep 2005 | - | $525.80 K(-14.4%) |
| Jun 2005 | $614.10 K(+195.7%) | $614.10 K(-35.5%) |
| Mar 2005 | - | $951.50 K(-16.8%) |
| Dec 2004 | - | $1.14 M(+522.8%) |
| Sep 2004 | - | $183.60 K(-11.6%) |
| Jul 2004 | $207.70 K(+4.4%) | $207.70 K(+6.2%) |
| Apr 2004 | - | $195.50 K(-26.9%) |
| Jan 2004 | - | $267.60 K(-24.6%) |
| Oct 2003 | - | $355.00 K(+78.4%) |
| Jul 2003 | $199.00 K(+340.3%) | $199.00 K(+155.1%) |
| Apr 2003 | - | $78.00 K(+40.5%) |
| Jan 2003 | - | $55.50 K(+28.8%) |
| Oct 2002 | - | $43.10 K(-4.6%) |
| Jul 2002 | $45.20 K(-70.8%) | $45.20 K(-1.5%) |
| Apr 2002 | - | $45.90 K(+21.8%) |
| Jan 2002 | - | $37.70 K(+82.1%) |
| Oct 2001 | - | $20.70 K |
| Jul 2001 | $155.00 K | - |
FAQ
- What is InMed Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual accounts receivable year-on-year change?
- What is InMed Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly accounts receivable year-on-year change?
What is InMed Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of INM is $352.80 K
What is the all time high annual accounts receivable for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual accounts receivable is $614.10 K
What is InMed Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, INM annual accounts receivable has changed by +$92.40 K (+35.48%)
What is InMed Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of INM is $284.70 K
What is the all time high quarterly accounts receivable for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly accounts receivable is $1.14 M
What is InMed Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, INM quarterly accounts receivable has changed by +$77.00 K (+37.07%)